EVP, CLO, CORP. SEC. Alaleh Nouri Sells 16,000 Shares of PROCEPT BioRobotics Corp
On January 9, 2024, Alaleh Nouri, EVP, CLO, CORP. SEC. of PROCEPT BioRobotics Corp, executed a sale of 16,000 shares of the company. The transaction was filed with the SEC and can be found in the SEC Filing. This recent sale is part of a series of transactions by the insider over the past year, which included the sale of 44,999 shares and no recorded purchases.
PROCEPT BioRobotics Corp, traded under the ticker NAS:PRCT, is a medical device company that specializes in the design, development, and commercialization of robotic surgical systems. The company's primary focus is on improving the lives of patients suffering from urological conditions through innovative robotic technologies.
The insider transaction history for PROCEPT BioRobotics Corp indicates a pattern of insider sales, with 13 recorded over the past year and no insider buys during the same period.
On the date of the insider's most recent transaction, shares of PROCEPT BioRobotics Corp were trading at $44.97, giving the company a market capitalization of $2.377 billion.
For investors monitoring insider activities, the trend of transactions may provide insights into the company's performance and insider perspectives on the stock's valuation. However, it is important to consider a wide range of factors when evaluating the potential implications of insider trades.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
